News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Statute Of Limitations A Huge Obstacle In Novartis Pharma K.K. (NVS) Case


6/13/2014 6:18:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The falsification of clinical trial data for the hypertension drug Diovan has resulted in the arrest of a former employee of Novartis Pharma K.K., making it a rare case in which authorities have taken action regarding irregularities in clinical research papers.

However, the pharmaceutical company’s organized involvement and the role of university researchers in the data falsification still remain unknown. Authorities seek to investigate the case further to uncover the whole picture.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES